[1]
Saad Muzaffar Azeem, “OPTIMIZING AMINOGLYCOSIDE DOSING IN CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE PATIENTS UNDERGOING INTERMITTENT HEMODIALYSIS: CARDIOVASCULAR IMPLICATIONS AND CLINICAL OUTCOMES”, J Popl Ther Clin Pharmacol, vol. 33, no. 2, pp. 1139–1149, Jul. 2026, doi: 10.69980/bn50yg38.